News Website

Breakthrough for endometriosis sufferers as new pill to be available on NHS - The Independent

Breakthrough for endometriosis sufferers as new pill to be available on NHS The Independent

Published: March 13, 2025, 5:37 a.m.

Read Full Article

Kerry hotel plays host to second annual Cneasu Endometriosis Inspired Women’s Health Retreat - Irish Independent

Kerry hotel plays host to second annual Cneasu Endometriosis Inspired Women’s Health Retreat Irish Independent

Published: March 13, 2025, 4 a.m.

Read Full Article

'First-of-a-kind' endometriosis tablet approved for use on NHS - This is the Coast

'First-of-a-kind' endometriosis tablet approved for use on NHS This is the Coast

Published: March 13, 2025, 3:01 a.m.

Read Full Article

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - MSN

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS MSN

Published: March 13, 2025, 1:21 a.m.

Read Full Article

Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.

To investigate the association between the duration of levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer risk in Korean women.

Published: March 13, 2025, midnight

Read Full Article

Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles.

To evaluate Dydrogesterone's effectiveness in PPOS protocols for IVF/ICSI or oocyte cryopreservation, focusing on LH surge suppression and metaphase II oocyte yield.

Published: March 13, 2025, midnight

Read Full Article

Dydrogesterone GnRH agonist LH surge in vitro fertilization metaphase II oocytes

Let’s Talk About It, Period: Could non-invasive test revolutionize endometriosis diagnosis? - Global News Kingston

Let’s Talk About It, Period: Could non-invasive test revolutionize endometriosis diagnosis? Global News Kingston

Published: March 12, 2025, 10:30 p.m.

Read Full Article

Harvard doctors sue Trump admin for removing LGBTQ+ health research - MassLive.com

Harvard doctors sue Trump admin for removing LGBTQ+ health research MassLive.com

Published: March 12, 2025, 8:47 p.m.

Read Full Article

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire

Published: March 12, 2025, 5:34 p.m.

Read Full Article

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer - Medscape

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer Medscape

Published: March 12, 2025, 4:51 p.m.

Read Full Article

Latest Articles

Breakthrough for endometriosis sufferers as new pill to be available on NHS - The Independent

Kerry hotel plays host to second annual Cneasu Endometriosis Inspired Women’s Health Retreat - Irish Independent

'First-of-a-kind' endometriosis tablet approved for use on NHS - This is the Coast

Breakthrough for endometriosis sufferers as first-of-its-kind pill to be available on NHS - MSN

Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence.

Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles.

Let’s Talk About It, Period: Could non-invasive test revolutionize endometriosis diagnosis? - Global News Kingston

Harvard doctors sue Trump admin for removing LGBTQ+ health research - MassLive.com

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer - Medscape

Subscribe to Our Newsletter